PLOD1 and type 2 diabetes mellitus: Since MF improves metabolic and hormonal indices and testicular morphology in T2DM, there is reason to believe that the testicular response to LH/hCG-R-agonists, reduced in diabetic pathology, can increase with MF treatment.